Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
TARA Mind is a public benefit corporation and health-tech company focused on expanding safe, affordable, and effective access to emerging mental health therapies, with an initial focus on treatment-resistant depression (TRD). Founded in 2022 by veteran Navy SEAL Marcus Capone and incubated by Red Cell Partners, the company operates a collaborative care platform that connects employers and their employees with a vetted national network of licensed therapists and clinics specializing in Ketamine-Assisted Therapy (KAT). TARA Mind partners with self-funded employers to offer its services as a supplemental health benefit, utilizing proprietary digital measurement-based care tools to track clinical outcomes and ensure safety. By integrating these advanced therapies into employer-sponsored health plans, TARA Mind aims to reduce healthcare costs and improve workforce productivity while addressing the systemic barriers to alternative mental health treatments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on TARA Mind.